Related Experiment Video
Updated: Oct 25, 2025

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
MicroRNAs, Multiple Sclerosis, and Depression
1Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu 30010, Taiwan.
Abstract:
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects the brain and spinal cord. There are several disease courses in MS including relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). Up to 50% of MS patients experience depressive disorders. Major depression (MD) is a serious comorbidity of MS. Many dysfunctions including neuroinflammation, peripheral inflammation, gut dysbiosis, chronic oxidative and nitrosative stress, and neuroendocrine and mitochondrial abnormalities may contribute to the comorbidity between MS and MD. In addition to these actions, medical treatment and microRNA (miRNA) regulation may also be involved in the mechanisms of the comorbidity between MS and MD. In the study, I review many common miRNA biomarkers for both diseases. These common miRNA biomarkers may help further explore the association between MS and MD.
Insights
This review explores common microRNA biomarkers linking multiple sclerosis (MS) and major depression (MD). Identifying shared biomarkers may illuminate the complex relationship between these two conditions.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Multiple sclerosis (MS) is a chronic central nervous system disease with various courses (RRMS, PPMS, SPMS).
- Major depression (MD) frequently co-occurs with MS, affecting up to 50% of patients.
- The MS-MD comorbidity is influenced by neuroinflammation, gut dysbiosis, oxidative stress, and neuroendocrine factors.
Purpose of the Study:
- To review common microRNA (miRNA) biomarkers associated with both multiple sclerosis and major depression.
- To explore the potential role of miRNA regulation in the comorbidity between MS and MD.
Main Methods:
- Literature review of studies investigating MS and MD.
- Analysis of common microRNA biomarkers identified in both conditions.
Main Results:
- Several microRNA biomarkers are implicated in both MS and MD.
- These shared biomarkers suggest a potential molecular link between the two diseases.
Conclusions:
- MicroRNAs represent promising biomarkers for understanding the MS-MD comorbidity.
- Further research into common miRNA biomarkers could reveal novel therapeutic targets.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs

